Does Induction PEG-Intron in Combination With Rebetol Enhance the Sustained Response Rates in Patients With CHC
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see which of two doses of PEG (polyethylene glycol)
interferon alfa-2b in combination with Ribavirin for 48 weeks is more effective at
elimination of hepatitis C.
The primary objective of this study is to compare the efficacy of Induction PEG-Interferon
alfa-2b (PEG-Intron) and Ribavirin (Rebetol) to standard PEG-Interferon alfa-2b (PEG-Intron)
and Ribavirin (Rebetol) in patients with chronic hepatitis C.